Brought to you by 
CSL acquires majority stake in Chinese plasma manufacturer Ruide for $352mm, plus earn-out
Jul 2017
Executive Summary
CSL Ltd. acquired an 80% stake in Humanwell Healthcare's Wuhan Zhong Yuan Rui De Biological Products Co. (Ruide), a manufacturer of plasma-based therapies, for $352mm in cash, which CSL will fund through an existing debt facility.
Deal Industry
-
Biotechnology
- Synthesis Technologies, Production Processes
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Acquisition of Private Biotech
- Payment Includes Cash
- Partial Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CSL acquires majority stake in Chinese plasma manufacturer Ruide for $352mm, plus earn-out
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice